Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teva Pharmaceutical (TEVA – Research Report), Globus Medical (GMED – Research Report) and DENTSPLY SIRONA (XRAY – Research Report).
Teva Pharmaceutical (TEVA)
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical, with a price target of $20.00. The company’s shares closed last Friday at $16.25, close to its 52-week high of $16.57.
According to TipRanks.com, Amsellem is a 1-star analyst with an average return of
Teva Pharmaceutical has an analyst consensus of Strong Buy, with a price target consensus of $18.17, a 13.1% upside from current levels. In a report issued on May 9, Barclays also maintained a Buy rating on the stock with a $20.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Globus Medical (GMED)
In a report released today, Matthew O’Brien from Piper Sandler maintained a Hold rating on Globus Medical, with a price target of $60.00. The company’s shares closed last Friday at $64.72, close to its 52-week high of $65.74.
According to TipRanks.com, O’Brien is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Globus Medical with a $67.22 average price target, representing a 4.7% upside. In a report issued on May 8, Needham also maintained a Hold rating on the stock.
DENTSPLY SIRONA (XRAY)
In a report released today, Jason Bednar from Piper Sandler maintained a Hold rating on DENTSPLY SIRONA, with a price target of $32.00. The company’s shares closed last Friday at $27.89, close to its 52-week low of $26.27.
According to TipRanks.com, Bednar is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
DENTSPLY SIRONA has an analyst consensus of Moderate Buy, with a price target consensus of $34.61, implying a 22.8% upside from current levels. In a report issued on May 2, Robert W. Baird also maintained a Hold rating on the stock with a $33.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TEVA:
